Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Enzyme conjugate and prodrug cancer therapy

Enzyme conjugate and prodrug cancer therapy

US Patent 9987241 · Granted Jun 5, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Formulations of tegavivint and related compounds2025
Gold nanoparticle-ligand conjugates and methods of use2024
Antimalarial enzyme conjugates, kits containing same, and methods of producing a2022
Formulations of tegavivint and related compounds2022
Compositions and methods for cancer treatment using targeted carbon nanotubes2016
Enzyme prodrug cancer therapy selectively targeted to tumor vasculature and meth2015
Compositions and methods for cancer treatment using targeted carbon nanotubes2013
Referrer cache chain2013
Chimeric proteins with phosphatidylserine binding domains2010
Chimeric proteins with phosphatidylserine binding domains2008
Fluoxetine enteric pellets and methods for their preparation and use2006
Fusion protein systems designed to increase soluble cytoplasmic expression of he2001